Treatment of coronary artery disease in dialysis patients with sirolimus-eluting stents: 1-year clinical follow-up of a consecutive series of cases.
From April 16, 2002 to October 16, 2002, 10 consecutive patients with coronary disease on chronic dialysis were treated with sirolimus-eluting stents. Diabetes was present in 30% and half of the patients had multivessel coronary disease. On average, patients had been on dialysis for 5 years prior to the procedure (range: 2-15 years). Five patients were on hemodialysis and 5 patients were on peritoneal dialysis. Overall, 18 lesions were treated with 1.9 +/- 1.1 sirolimus-eluting stents per patient. At a mean follow-up of 403 days, there were no cases of death, myocardial infarction, or target lesion revascularization.
Daemen
Joost
J
Erasmus Medical Center, Catheterization Laboratory Thoraxcenter 416a, Dr. Molewaterplein, 40, 3015 GD, Rotterdam, The Netherlands. joostdaemen@chello.nl
Lemos
Pedro
P
Aoki
Jiro
J
Arampatzis
Chourmouzios
C
Hoye
Angela
A
McFadden
Eugene
E
Serruys
Patrick
P
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015906:Angioplasty, Balloon, Coronary; D003324:Coronary Artery Disease / Q000473:pathology / Q000628:therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D006435:Renal Dialysis; D020123:Sirolimus / Q000008:administration & dosage*; D015607:Stents; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D020123:Sirolimus